ADVFN US – Market Content Editor

  • Yext jumps on announcement of $180 million share tender offer

    Yext jumps on announcement of $180 million share tender offer

    Shares of Yext, Inc. (NYSE:YEXT) surged on Tuesday after the brand visibility software company unveiled plans for a $180 million share buyback through a “modified Dutch auction” tender offer. The stock climbed about 11% after Yext said it intends to repurchase up to $180 million of its common shares at prices ranging from $5.75 to…

  • Blackbaud rallies after Q4 beat and bullish 2026 guidance

    Blackbaud rallies after Q4 beat and bullish 2026 guidance

    Blackbaud (NASDAQ:BLKB) posted fourth-quarter results on Tuesday that topped market expectations and paired them with a stronger-than-anticipated outlook for 2026, sending shares sharply higher. The AI-driven social impact software company’s stock jumped 6.74% in pre-market trading following the announcement. Adjusted earnings for the quarter came in at $1.19 per share, ahead of the analyst consensus…

  • Masco climbs as upbeat 2026 guidance outweighs modest Q4 revenue miss

    Masco climbs as upbeat 2026 guidance outweighs modest Q4 revenue miss

    Masco Corporation (NYSE:MAS) reported fourth-quarter adjusted earnings on Tuesday that came in ahead of market expectations, and investors focused on a stronger-than-anticipated outlook for 2026. Shares rose 4.84% in pre-market trading following the release. The home improvement and building products group delivered adjusted earnings per share of $0.82 for the quarter, topping the analyst consensus…

  • RH slides as real estate chief departs for Crate & Barrel

    RH slides as real estate chief departs for Crate & Barrel

    Shares of RH (NYSE:RH) moved lower in premarket trading, falling 1.3%, after the luxury home furnishings group announced the departure of another senior executive, extending a recent run of leadership changes. Steve Rouman, the company’s Senior Vice President of Real Estate, has stepped down to take on the role of Chief Real Estate & Development…

  • Duke Energy narrowly beats Q4 profit forecasts, outlook tracks expectations

    Duke Energy narrowly beats Q4 profit forecasts, outlook tracks expectations

    Duke Energy (NYSE:DUK) reported fourth-quarter earnings on Tuesday that came in just ahead of analyst estimates, while issuing 2026 guidance broadly in line with market expectations. The utility’s shares dipped 0.18% in pre-market trading following the release. For the fourth quarter of 2025, Duke Energy posted adjusted earnings per share of $1.50, edging past consensus…

  • Fiserv tops Q4 profit forecasts as revenue narrowly misses; shares little changed

    Fiserv tops Q4 profit forecasts as revenue narrowly misses; shares little changed

    Fiserv, Inc. (NASDAQ:FISV) posted fourth-quarter adjusted earnings on Tuesday that came in ahead of Wall Street expectations, even as revenue fell just short of forecasts. The payments and financial technology group’s shares were little changed in pre-market trading, slipping 0.23% following the results. Adjusted earnings per share for the quarter totaled $1.99, above the analyst…

  • Vestis falls short in Q1 as weaker revenue drags earnings

    Vestis falls short in Q1 as weaker revenue drags earnings

    Vestis Corporation (NYSE:VSTS) reported first-quarter fiscal 2026 results on Tuesday that missed market expectations, as softer revenue weighed on profitability. The uniform and workplace supplies provider posted adjusted earnings of $0.10 per share, well below the analyst consensus of $0.27. Revenue totaled $663.4 million, missing forecasts of $763.69 million and marking a 3% year-on-year decline.…

  • Nektar gains after durable efficacy shown in atopic dermatitis study

    Nektar gains after durable efficacy shown in atopic dermatitis study

    Shares of Nektar Therapeutics (NASDAQ:NKTR) moved higher on Tuesday after the company released encouraging long-term maintenance results from its REZOLVE-AD trial of rezpegaldesleukin in patients with moderate-to-severe atopic dermatitis. The stock was up about 3% in morning trading. The clinical-stage biotech said patients receiving rezpegaldesleukin, a regulatory T-cell–targeting biologic, sustained strong clinical responses through week…

  • Entegris jumps after Q4 beat and upbeat Q1 guidance

    Entegris jumps after Q4 beat and upbeat Q1 guidance

    Entegris, Inc. (NASDAQ:ENTG) shares surged on Tuesday after the company reported fourth-quarter results that came in ahead of expectations and issued stronger-than-anticipated guidance for early 2026. The advanced materials supplier’s stock rose 6.99% in pre-market trading following the announcement. For the quarter, Entegris delivered adjusted earnings of $0.70 per share, topping the analyst consensus of…

  • Unity shares jump after Oppenheimer upgrade highlights AI upside

    Unity shares jump after Oppenheimer upgrade highlights AI upside

    Unity Software (NYSE:U) climbed about 5% in Tuesday morning trading after Oppenheimer upgraded the stock to Outperform from Perform and introduced a $38 price target. The call comes after a tough stretch for Unity, which has lagged amid broader weakness in software names tied to concerns around artificial intelligence. The stock finished Monday at $27.53,…